Every story and comment from the Hacker News API, in a layout borrowed from 2001.
A comment on FDA considers first CRISPR gene editing treatment that may cure sickle cell. Parent comment
The research and the approval are extremely expensive and risky. Without a boatload of cash at the end of the tunnel, nobody would do it.
Patents will expire and in a generation, this will become cheap.
There are no comments on this comment yet.
The research and the approval are extremely expensive and risky. Without a boatload of cash at the end of the tunnel, nobody would do it.
Patents will expire and in a generation, this will become cheap.